Key result
Partial ZC3HC1 reduction drives neointima formation, while complete loss induces smooth muscle cell quiescence.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
ZC3HC1 acts as a dosage-sensitive modulator of SMC phenotype, providing mechanistic insight into the rs11556924-T allele and identifying it as a potential target for vascular disease.
ZC3HC1 acts as a dosage-sensitive modulator of SMC phenotype. Partial reduction promotes a synthetic, proliferative state and neointima formation, while complete loss induces a quiescent phenotype. These findings provide mechanistic insight into the paradoxical clinical associations of the rs11556924-T allele and identify ZC3HC1 as a potential target for modulating SMC phenotypes in vascular disease.
Aherrahrou et al. (2026) studied Vascular disease. ZC3HC1 deficiency vs. Normal ZC3HC1 levels was evaluated on Smooth muscle cell phenotype and neointima formation. Partial reduction of ZC3HC1 promotes a synthetic, proliferative smooth muscle cell state and neointima formation, while complete loss induces a quiescent phenotype.
Synapse has enriched 10 related papers. Consider them for comparative context: